- $87.36bn
- $94.62bn
- $308.95bn
- 83
- 41
- 96
- 86
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.93 | ||
| PEG Ratio (f) | 1.73 | ||
| EPS Growth (f) | 12.32% | ||
| Dividend Yield (f) | 0.43% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 53.47 | ||
| Price to Sales | 0.25 | ||
| EV to EBITDA | 20.17 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 32.33% | ||
| Return on Equity | n/a | ||
| Operating Margin | 1.17% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 231,051 | 238,228 | 263,966 | 276,711 | 308,951 | 362,451.41 | 400,115.86 | 7.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -20.55 | +14.98 | +90.58 | +93.74 | -13.76 | +46.05 | +12.32 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
McKesson Corporation is a provider of diversified healthcare services. It is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment includes its operations in Norway, which provides distribution and services to wholesale and retail customers.
Directors
- Edward Mueller NEC (74)
- Brian Tyler CEO (54)
- Britt Vitalone CFO (52)
- Tracy Faber CHO (51)
- Nancy Flores EVP (54)
- Lori Schechter EVP (59)
- Tom Rodgers EVP (50)
- Kevin Emerson SVP (49)
- James Hinton DRC
- Kathleen Wilson - Thompson DRC
- Richard Carmona IND
- Dominic Caruso IND (64)
- Donald Knauss IND (70)
- Brad Lerman IND (64)
- Linda Mantia IND (52)
- Maria Martinez IND (63)
- Susan Salka IND (56)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 7th, 1994
- Public Since
- November 10th, 1994
- No. of Shareholders
- 4,160
- No. of Employees
- 45,000
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 125,326,376
- Address
- 6555 State Highway 161, IRVING, 75039
- Web
- https://www.mckesson.com/
- Phone
- +1 9724464800
- Auditors
- Deloitte & Touche LLP
Upcoming Events for MCK
Q4 2025 Mckesson Corp Earnings Call
McKesson Corp Annual Shareholders Meeting
Q1 2026 Mckesson Corp Earnings Release
Similar to MCK
Abbvie
New York Stock Exchange
Bausch Health Companies
New York Stock Exchange
Bristol-Myers Squibb Co
New York Stock Exchange
Bristol-Myers Squibb Co
New York Stock Exchange
Cardinal Health
New York Stock Exchange
FAQ
What is the McKesson share price?
As of Today at 21:57 UTC, shares in McKesson are trading at $697.08. This share price information is delayed by 15 minutes.
How has the McKesson share price performed this year?
Shares in McKesson last closed at $697.08 and the price had moved by +32.54% over the past 365 days. In terms of relative price strength the McKesson share price has outperformed the S&P500 Index by +24.63% over the past year.
What are the analyst and broker recommendations for McKesson?
The overall consensus recommendation for McKesson is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the McKesson dividend yield?
The McKesson dividend yield is 0.37% based on the trailing twelve month period.
Does McKesson pay a dividend?
Last year, McKesson paid a total dividend of $2.57, and it currently has a trailing dividend yield of 0.37%. We do not have any data on when McKesson is to next pay dividends.
When does McKesson next pay dividends?
We do not have data on when McKesson is to next pay dividends. The historic dividend yield on McKesson shares is currently 0.37%.
How do I buy McKesson shares?
To buy shares in McKesson you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of McKesson?
As of the previous close price of $697.08, shares in McKesson had a market capitalisation of $87.36bn.
Where are McKesson shares listed?
Here are the trading details for McKesson:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: MCK
What kind of share is McKesson?
Based on an overall assessment of its quality, value and momentum McKesson is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a McKesson share price forecast for 2025?
The analyst consensus target price for shares in McKesson is $711.38. That is 2.05% above the last closing price of $697.08.
Analysts covering McKesson currently have a consensus Earnings Per Share (EPS) forecast of $32.78 for the next financial year.
Find out moreWhat is the trend in the McKesson share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like McKesson. Over the past six months, its share price has outperformed the S&P500 Index by +51.7%.
As of the last closing price of $697.08, shares in McKesson were trading +19.27% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the McKesson PE Ratio?
The McKesson PE ratio based on its reported earnings over the past 12 months is 18.93. The shares last closed at $697.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of McKesson?
McKesson's management team is headed by:
- Edward Mueller - NEC
- Brian Tyler - CEO
- Britt Vitalone - CFO
- Tracy Faber - CHO
- Nancy Flores - EVP
- Lori Schechter - EVP
- Tom Rodgers - EVP
- Kevin Emerson - SVP
- James Hinton - DRC
- Kathleen Wilson - Thompson - DRC
- Richard Carmona - IND
- Dominic Caruso - IND
- Donald Knauss - IND
- Brad Lerman - IND
- Linda Mantia - IND
- Maria Martinez - IND
- Susan Salka - IND